Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.

Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.

Item
http://www.wikidata.org/entity/Q38814812
Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer developmentGenomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.Predicting the Correlation of EZH2 and Cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression.Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.Expression of EZH2 in uveal melanomas patients and associations with prognosis.Impact of pretreatment plasma D-dimer levels and its perioperative change on prognosis in operable esophageal squamous cell carcinoma.EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma.Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells.EZH2-mediated suppression of lncRNA-LET promotes cell apoptosis and inhibits the proliferation of post-burn skin fibroblasts.
P2860

Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.

Item
http://www.wikidata.org/entity/Q38814812
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aberrant overexpression of EZH ...... amous cell carcinoma patients.
@en
type
label
Aberrant overexpression of EZH ...... amous cell carcinoma patients.
@en
prefLabel
Aberrant overexpression of EZH ...... amous cell carcinoma patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Aberrant overexpression of EZH ...... amous cell carcinoma patients.
@en
P2093
P2860
P304
P31
P356
10.3109/1354750X.2015.1118537
P433
P478
P577
P698
P921